Pharmaceutical Benefits Scheme electronic Chemotherapy Medication Chart project

The Pharmaceutical Benefits Scheme electronic Chemotherapy Medication Chart (PBS eCMC) project has provided recommendations on the minimum information requirements for inclusion on a PBS eCMC.

Overview

In 2020 the Australian Government Department of Health (the Department) engaged the Commission to develop minimum information requirements for a PBS eCMC to support safe prescribing, administration, dispensing and claiming of PBS and non-PBS chemotherapy medicines.

Once legislated, these information requirements will underpin a standardised approach to the way electronic information is made available to support safe electronic prescribing, dispensing, PBS claiming and administration of chemotherapy and anticancer related medicines in hospitals, for children and adults.

The PBS eCMC project is the first phase of a multi-phase project by the Department to support electronic prescribing of chemotherapy medicines in hospitals and other defined care settings.

This work will inform phase 2 of the simplified prescribing arrangements that have been developed to support supply of chemotherapy and supportive medicines during the COVID-19 pandemic. 

About the project

Project stages

The PBS eCMC project was managed through a number of specific project stages. Each stage was supported by the Electronic Chemotherapy Medication Chart Expert Advisory Group (EAG). 

Project stages included:

  • A national survey to understand how oncology systems currently support chemotherapy medication management workflows
  • literature review and environmental scan provided clarity around the key safety and quality issues shaping contemporary chemotherapy medication management in Australian hospitals
  • Iterative consultations with peak bodies and key stakeholder groups to ensure the utility of the final PBS eCMC recommendations.

Electronic Chemotherapy Medication Chart Expert Advisory Group (EAG)

The project was guided by an expert advisory group (EAG) composed of members with a broad cross-section of experience in, and knowledge of, chemotherapy medication management and oncology systems used in the sector. The EAG also included safety and system specialists, as well as a consumer representative (who was able to bring lived experiences to the attention of the broader group). A representative from the Australian Digital Health Agency (ADHA) was also included as part of the membership to ensure the final information requirements were aligned with existing processes and expectations for uptake into the electronic prescribing conformance framework.

Given the experience of EAG members, information was exchanged during meetings in relation to the capacity of existing systems to document some of the information requirements under consideration. The EAG comprised 19 members from across the country.

Project stages

The PBS eCMC project was managed through a number of specific project stages. Each stage was supported by the Electronic Chemotherapy Medication Chart Expert Advisory Group (EAG). 

Project stages included:

  • A national survey to understand how oncology systems currently support chemotherapy medication management workflows
  • literature review and environmental scan provided clarity around the key safety and quality issues shaping contemporary chemotherapy medication management in Australian hospitals
  • Iterative consultations with peak bodies and key stakeholder groups to ensure the utility of the final PBS eCMC recommendations.

Electronic Chemotherapy Medication Chart Expert Advisory Group (EAG)

The project was guided by an expert advisory group (EAG) composed of members with a broad cross-section of experience in, and knowledge of, chemotherapy medication management and oncology systems used in the sector. The EAG also included safety and system specialists, as well as a consumer representative (who was able to bring lived experiences to the attention of the broader group). A representative from the Australian Digital Health Agency (ADHA) was also included as part of the membership to ensure the final information requirements were aligned with existing processes and expectations for uptake into the electronic prescribing conformance framework.

Given the experience of EAG members, information was exchanged during meetings in relation to the capacity of existing systems to document some of the information requirements under consideration. The EAG comprised 19 members from across the country.

Proposed PBS eCMC information requirements

The proposed PBS eCMC information requirements have been provided to the Department to inform phase 2 of the simplified prescribing arrangements. The Commission will continue to work with the Department as the PBS eCMC legislative instrument is finalised. 

Frequently asked questions

Questions?

For more information about the PBS eCMC project, please email medsafety@safetyandquality.gov.au